Pharmacoeconomic analysis of erlotinib versus pemetrexed in the treatment of advanced non-small cell lung cancer
ZHANG Chun-xiang
ZHANG Hong-mei
SHI Jin-ning
WANG Dong
MA Ai-xia
Keywords：erlotinibpemetrexednon-small cell lung cancer (NSCLC)pharmacoeconomic analysis
Publication Date：2015-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)